Fernanda Musa

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

Ramez N. Eskander, Michael W. Sill, Lindsey Beffa et al. · New England Journal of Medicine · 2023 · 626 citations · Full text

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)

S. Dennis, Fernanda Musa, Fanny Dao et al. · Gynecologic Oncology · 2011 · 270 citations

Randomized Eortc-ncic Trial, Identical Time Period, Gynecologic Surgery +11

Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer

Fernanda Musa, Amandine Alard, Gizelka David‐West et al. · Molecular Cancer Therapeutics · 2016 · 69 citations · Full text

Neoadjuvant chemotherapy in patients with advanced endometrial cancer

Olivia R Khouri, Melissa K. Frey, Fernanda Musa et al. · Cancer Chemotherapy and Pharmacology · 2019 · 43 citations

Medicine, Cancer Management, Gynecology +4

Mucinous histology is a risk factor for nodal metastases in endometrial cancer

Fernanda Musa, Marilyn Huang, Brandi N. Adams et al. · Gynecologic Oncology · 2012 · 33 citations

Tumoral Pathology, Nodal Metastases, Mucinous Histology +9